New trial to drive forward promising treatment for dyskinesia
Parkinson’s UK is joining forces with US charity The Michael J. Fox Foundation and biopharma company Neurolixis to fund a £1.5m clinical trial of an exciting new drug to combat dyskinesia in people with Parkinson’s.
Could an anti-sickness drug treat hallucinations in Parkinson's?
We're funding a new research study into a possible treatment for hallucinations in Parkinson's.
Research finds air pollution may speed up Parkinson's
Researchers in the US have uncovered a link between long-term exposure to pollution and deterioration in health conditions. This includes Parkinson's and Alzheimer's.
Driving research forward during the coronavirus pandemic
A survey of people with Parkinson’s, their carers and loved ones has shown that the majority are still comfortable taking part in research. 548 responses have shaped guidance aimed at researchers. It will help them adapt their studies to ensure the safety and comfort of people with Parkinson's during the coronavirus (COVID-19) pandemic.
Oxford researchers find molecule that may slow or stop the progress of Parkinson's
Parkinson's UK funded research suggests it may be possible to prevent the formation of protein clumps that cause problems in Parkinson's by using microscopic tweezers that pull apart the proteins. This could pave the way for a therapy that could slow or stop the progression of the condition.
$161M worth of Parkinson’s research funding awarded across the globe
The Aligning Sciences Across Parkinson’s (ASAP) initiative has announced the 21 teams to receive grant funding. The ambitious programme aims to accelerate the pace of discovery towards a cure for Parkinson’s.
Trial results show statin drug does not slow Parkinson's
Simvastatin is a drug already used to lower cholesterol, and prevent heart attacks and strokes. Initial results from a major clinical trial show it doesn't have potential to slow the progression of Parkinson's as previously hoped.
Precious brain tissue uncovers new insights about the causes of Parkinson’s
Tissue from the Parkinson’s UK Brain Bank has provided vital clues to why brain cells are lost in Parkinson's
New research uncovers structures of Parkinson’s-related protein
Scientists at the University Bath have improved our understanding of the potentially toxic structures that the protein, alpha-synuclein, can form.